# Regenerative therapy basics in plain words *Regenerative Therapy Basics | Regenerative Therapy Glendale* > Regenerative therapy Glendale basics, including what PRP is, what results may mean and what to ask at a visit. Glendale stretches across many miles. After a long drive, you'll notice knee or hip stiffness. The soreness may ease after several steps. It can return after more walking. That timing helps a clinician understand the joint. ## What to know about regenerative therapy Regenerative therapy is care a clinician prepares from blood or tissue and places into the joint by needle. PRP starts with blood drawn from your arm. Spinning keeps the blood portion with extra platelets. These small blood parts stop bleeding and hold proteins used in healing. Concentrated PRP has a larger amount of them after spinning. You'll hear these blood- or tissue-based choices called biologic therapies. ## What a better-feeling joint can mean Less soreness may make walking, stairs or sleep easier. You'll value that even when an x-ray looks unchanged. The catch is that relief doesn't prove new cartilage grew. Cartilage is the slick tissue coating each bone end. Think of relief as lowering a radio. It doesn't replace the radio. Judge the result by a daily task you want back. ## What to ask before choosing PRP You'll need to ask what will be taken from your body. Then ask how it will be prepared and returned. QC Kinetix offers regenerative treatment options that its medical providers, meaning joint clinicians, prepare at the clinic from your blood or tissue and place by needle without surgery. Ask how many visits are involved. Also ask what movement is safe afterward. Don't agree until each step makes sense. ## What to expect from the choice You might feel less sore after PRP. Someone else won't feel enough change to justify the cost. Joints don't all respond alike. Clinics also spin blood in different ways. Nobody can promise your result. You'll probably still need exercise as part of joint care. Feeling better isn't proof that worn tissue was rebuilt. ## Sources 1. FDA states plainly that no stem cell, exosome, stromal vascular fraction, umbilical cord blood, Wharton's jelly or amniotic-fluid product has been approved for the treatment of ANY orthopedic condition - it names osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain and shoulder pain individually. The only FDA-approved stem cell products in the United States are cord-blood-derived blood-forming stem cells for disorders of the hematopoietic system, and there are currently no FDA-approved exosome products. US Food and Drug Administration, Center for Biologics Evaluation and Research — [Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes](https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/consumer-alert-regenerative-medicine-products-including-stem-cells-and-exosomes). *FDA*, 2020. 2. The RESTORE trial - a participant-, injector- and assessor-blinded RCT of 288 adults aged 50+ with symptomatic medial knee OA (Kellgren-Lawrence 2-3) - compared three weekly intra-articular PRP injections against saline placebo, with co-primary endpoints of 12-month knee pain and medial tibial cartilage volume on MRI. PRP did not beat placebo on either. It is the single best-designed test of the specific claim that PRP changes joint structure, and it was negative. Bennell KL, et al. — [Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial.](https://pubmed.ncbi.nlm.nih.gov/34812863/). *JAMA*, 2021. DOI: 10.1001/jama.2021.19415. 3. A four-arm, multicentre, single-blind phase 2/3 randomized trial of 480 knee OA patients (KL II-IV) compared autologous bone marrow aspirate concentrate, autologous adipose stromal vascular fraction and allogeneic umbilical-cord-tissue mesenchymal stromal cells against a corticosteroid injection control. At 12 months NONE of the three orthobiologic injections was superior to another, or to the corticosteroid control, and none of the four groups showed a significant change in MRI osteoarthritis score from baseline. No procedure-related serious adverse events occurred. Mautner K, et al. — [Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial.](https://pubmed.ncbi.nlm.nih.gov/37919438/). *Nature medicine*, 2023. DOI: 10.1038/s41591-023-02632-w. 4. A 2026 systematic review and meta-analysis of 28 randomized trials of intra-articular mesenchymal stem cell-based therapies in knee OA found significant improvements in several pain and function measures (delta-VAS MD -1.67; KOOS pain MD 15.37) but NO significant difference in WOMAC, KOOS quality of life or the Lequesne index, and MRI-based WORMS scores were non-significant - indicating no consistent structural benefit. Its own conclusion: these therapies serve a primarily SYMPTOM-modifying rather than STRUCTURE-modifying role, with higher frequencies of local reactions to weigh against the symptomatic benefit. Awad G, et al. — [Efficacy and safety of intra-articular mesenchymal stem cell-based therapies in knee osteoarthritis: A systematic review and meta-analysis of randomized controlled trials.](https://pubmed.ncbi.nlm.nih.gov/41863718/). *Clinical rheumatology*, 2026. DOI: 10.1007/s10067-026-08042-w. 5. A GRADE-rated systematic review and meta-analysis of 16 randomized trials (807 participants) found that MSC therapy for chronic knee OA pain PROBABLY RESULTS IN LITTLE TO NO DIFFERENCE in pain relief at 3-6 months (WMD -0.74 cm on a 10 cm VAS against a minimally important difference of 1.5 cm) or physical functioning (WMD 2.23 on the SF-36 100-point subscale against a 10-point MID), both moderate certainty; at 12 months pain was again probably little-to-no-different (WMD -0.73 cm). The measured effect is real but sits BELOW the threshold at which a patient would notice it. Sadeghirad B, et al. — [Mesenchymal stem cells for chronic knee pain secondary to osteoarthritis: A systematic review and meta-analysis of randomized trials.](https://pubmed.ncbi.nlm.nih.gov/38777213/). *Osteoarthritis and cartilage*, 2024. DOI: 10.1016/j.joca.2024.04.021. ## What to bring when you call Keep your medicine names, joint notes and main daily goal nearby. The clinic can explain what happens during an exam. It can also describe available treatment choices and both locations. Schedule a free consultation: --- Understand the soreness. Know what to try. Find local care. Learn why a joint aches, which home measures help, when care is urgent and where QC Kinetix clinics are located. Plain help for understanding joint soreness, home steps and local care choices in Glendale. This site is operated by the owners of the QC Kinetix Phoenix-area clinics, including the Peoria and Banner Estrella locations named here, and those owners benefit when a reader books a consultation. © 2026 Glendale Regenerative Guide. General education only; a clinician who knows your history should guide decisions about your care.